Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV Research and Treatment, and Hepatitis C virus research.
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study
Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study
Screening and vaccination against COVID-19 to minimise school closure: a modelling study
Breakthrough Infections after Postexposure Vaccination against Mpox
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers
Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study
Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France
A Healthcare-Associated Infection With Monkeypox Virus of a Healthcare Worker During the 2022 Outbreak
Myocarditis in monkeypox-infected patients: a case series
Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1
Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death
Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study
Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France
Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis
Strengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks
Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients.
COVID-19 vaccines: A race against time
Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March–May 2020)